Akèy › Siròz fwa bilè
Etid klinik pou Siròz fwa bilè ap rekrite nan Etazini
8 etid pou Siròz fwa bilè ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06016842Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07424677Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06051617Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Ap rekriteFaz 1
Laj 18 a 80 · Tout sèks · Mizajou Sep 14, 2026 · NCT06825559Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Aug 31, 2026 · NCT07556913Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07216235Biobank for Cholestatic Liver Diseases.
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 85 · Tout sèks · Mizajou Feb 17, 2026 · NCT03445585Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou May 29, 2025 · NCT01793168Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.